FDA NDC Directory · JSON-LD · Markdown

HEPCLUDEX

NDC 61958-3104 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameBULEVIRTIDE
Labeler / ManufacturerGilead Sciences, Inc.
Marketing categoryBiologic License Application · App BLA761468
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · SUBCUTANEOUS
Active ingredientsBULEVIRTIDE ACETATE (8.5 mg/1)
Marketing started20260522
Package count1

External sources

Source: openFDA. Public-domain (CC0).